Both in Biotechnology
Revolution Medicines vs Repligen
Over the past year RVMD returned +241.0% and RGEN returned +21.3%; their daily moves had a correlation of 0.16.
RVMD +241.0% RGEN +21.3%Growth of $1, one year, split-adjusted
| Metric | RVMD | RGEN |
|---|---|---|
| Price | $199.70 | $178.20 |
| Market cap | $42.80B | $11.31B |
| Today | +2.82% | −0.04% |
| 1 month | −0.1% | +1.9% |
| 6 months | +32.2% | +41.7% |
| Year to date | +150.7% | +8.8% |
| 1 year | +236.6% | +18.7% |
| Revenue growth (YoY) | — | +10.9% |
| Gross margin | — | 53.0% |
| Net margin | — | −18.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 14.0× |
| Net cash | $3.45B | $307.4M |
| Dividend yield | — | — |
| Volatility (60d) | 39.9% | 47.3% |
| Short % of float | 6.4% | 12.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).